Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), a leading licensed cannabis producer, has announced it will release its fourth quarter and fiscal 2024 financial results on December 18, 2024, before market open. The company will host a conference call at 8:00 am Eastern Time on the same day to discuss the results. Interested participants must register in advance to join the call, and a webcast replay will be available within 24 hours after the call's conclusion, remaining accessible for 90 days on the company's investor relations website.
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), un importante produttore di cannabis autorizzato, ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'anno fiscale 2024 il 18 dicembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una teleconferenza alle 8:00 ora orientale dello stesso giorno per discutere i risultati. I partecipanti interessati devono registrarsi in anticipo per partecipare alla chiamata, e una registrazione web sarà disponibile entro 24 ore dalla conclusione della chiamata, rimanendo accessibile per 90 giorni sul sito web delle relazioni con gli investitori dell'azienda.
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), un destacado productor autorizado de cannabis, ha anunciado que presentará sus resultados financieros del cuarto trimestre y del ejercicio fiscal 2024 el 18 de diciembre de 2024, antes de la apertura del mercado. La compañía llevará a cabo una llamada de conferencia a las 8:00 a.m. hora del Este el mismo día para discutir los resultados. Los participantes interesados deben registrarse con anticipación para unirse a la llamada, y una repetición de la transmisión en línea estará disponible dentro de las 24 horas después de la conclusión de la llamada, siendo accesible durante 90 días en el sitio web de relaciones con inversores de la empresa.
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), 주요 합법 대마초 생산업체가 2024 회계 연도 4분기 재무 결과를 2024년 12월 18일, 시장 개장 전에 발표할 예정이라고 밝혔습니다. 회사는 같은 날 동부 표준시 오후 8시에 결과에 대해 논의하는 전화 회의를 개최할 예정입니다. 관심 있는 참가자는 전화 회의에 참여하기 위해 사전에 등록해야 하며, 회의 종료 후 24시간 이내에 웹캐스트 재생이 제공되며, 회사의 투자자 관계 웹사이트에서 90일 동안 접근할 수 있습니다.
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), un producteur de cannabis autorisé de premier plan, a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'exercice 2024 le 18 décembre 2024, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique à 8h00, heure de l'Est, le même jour pour discuter des résultats. Les participants intéressés doivent s'inscrire à l'avance pour rejoindre l'appel, et un replay du webinaire sera disponible dans les 24 heures suivant la fin de l'appel, restant accessible pendant 90 jours sur le site web des relations investisseurs de l'entreprise.
Organigram Holdings (NASDAQ: OGI) (TSX: OGI), ein führender lizenzierter Cannabisproduzent, hat angekündigt, dass es am 18. Dezember 2024 vor Markteröffnung seine Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Interessierte Teilnehmer müssen sich im Voraus registrieren, um an der Konferenz teilzunehmen, und eine Aufzeichnung der Webübertragung wird innerhalb von 24 Stunden nach dem Ende der Konferenz verfügbar sein und für 90 Tage auf der Website der Investor Relations des Unternehmens zugänglich bleiben.
- None.
- None.
The Company will host a conference call to discuss its results with details as follows:
Date: Wednesday, December 18, 2024
Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
https://registrations.events/direct/Q4I96766465
To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.
To access the webcast:
https://events.q4inc.com/attendee/453820675
Participants will receive their details via email.
A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc. a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211105697/en/
For Media enquiries:
Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
For Investor Relations enquiries:
Max Schwartz, Director of Investor Relations
investors@organigram.ca
Source: Organigram Holdings Inc.
FAQ
When will Organigram (OGI) release its Q4 and fiscal 2024 earnings?
What time is Organigram's (OGI) Q4 2024 earnings call?
How long will Organigram's (OGI) Q4 2024 earnings webcast be available?
Where can I access Organigram's (OGI) Q4 2024 earnings webcast replay?
